Glioma
Research from CSL Limited broadens understanding of glioma
Published in Cancer Weekly, May 13th, 2008
"In the present study we investigated whether allogeneic glioma cells can be utilized to evoke prophylactic or therapeutic immune-mediated elimination of syngeneic glioma in two rat strains. Fisher 344 and Sprague-Dawley (SD) rats were injected with two syngeneic glioma cell lines, 9L and C6, respectively, resulting in progressive tumor growth. 9L is syngeneic to the Fisher 344 and allogeneic to the SD rats, while C6 cells are syngeneic to SD rats and allogeneic to Fisher 344 rats," scientists writing in the journal Vaccine report.
"Both rat strains were subcutaneously injected with their respective allogeneic tumor cells, which proved unable to grow...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2008-05-13)
More Articles from Cancer Weekly
- Breast Cancer
Data Show Preoperative Assessment of Breast Cancer Patients Enables Early Diagnosis, Successful Treatment of Lymphedema - Cancer Gene Therapy
Researchers from Fourth Military Medical University provide details of new studies and findings in the area of cancer gene therapy - Cancer Vaccines
Research from Shanghai Jiao Tong University has provided new data on cancer vaccines - Cancer Vaccines
Research on cancer vaccines described by D. Atanackovic and colleagues - Cancer Vaccines
Research reports on cancer vaccines from E.N. Vinageras and colleagues provide new insights - Cytori Therapeutics
Cytori Begins Breast Reconstruction Study in Europe - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
